BIOMARIN PHARMACEUTICAL INC Quarterly Other Assets, Noncurrent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Biomarin Pharmaceutical Inc quarterly Other Assets, Noncurrent history and growth rate from Q2 2010 to Q3 2024.
  • Biomarin Pharmaceutical Inc Other Assets, Noncurrent for the quarter ending September 30, 2024 was $199M, a 20.7% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $199M +$34.2M +20.7% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $191M +$46.6M +32.3% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $185M +$34.7M +23.1% Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $172M -$4.7M -2.67% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 $165M +$13.3M +8.75% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $144M -$7.63M -5.03% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $150M +$871K +0.58% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 $176M +$24.1M +15.9% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $152M +$7.08M +4.9% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $152M +$10.1M +7.15% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $149M +$7.99M +5.66% Mar 31, 2022 10-Q 2022-04-29
Q4 2021 $152M +$9.88M +6.95% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $145M +$25.7M +21.6% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $142M +$5.81M +4.28% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $141M +$15.3M +12.1% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $142M +$20.2M +16.6% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $119M +$6.36M +5.65% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $136M +$36.4M +36.6% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $126M +$29.6M +30.8% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $122M +$85.4M +234% Dec 31, 2019 10-K 2021-02-26
Q3 2019 $113M +$75.1M +200% Sep 30, 2019 10-Q/A 2019-11-04
Q2 2019 $99.5M +$60M +152% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 $96.3M +$63.6M +195% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 $36.6M +$6.72M +22.5% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $37.6M +$14.6M +63.4% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 $39.4M +$18M +83.8% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $32.7M +$6.09M +22.9% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $29.9M -$2.96M -9.03% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $23M -$13.5M -36.9% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 $21.4M -$1.61M -6.98% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 $26.6M +$1.18M +4.65% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $32.8M -$376M -92% Dec 31, 2016 10-K 2018-02-26
Q3 2016 $36.4M -$24.3M -40.1% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $23.1M -$35.2M -60.4% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $25.4M -$54.9M -68.4% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 $409M +$354M +649% Dec 31, 2015 10-K 2017-02-27
Q3 2015 $60.8M -$742K -1.21% Sep 30, 2015 10-Q 2015-11-02
Q2 2015 $58.3M +$11.7M +25.2% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $80.3M +$38.8M +93.4% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 $54.6M -$102M -65.1% Dec 31, 2014 10-K 2016-02-29
Q3 2014 $61.5M +$47.5M +339% Sep 30, 2014 10-Q 2014-10-28
Q2 2014 $46.6M +$31.7M +213% Jun 30, 2014 10-Q 2014-07-31
Q1 2014 $41.5M +$26.4M +174% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 $156M +$137M +699% Dec 31, 2013 10-K 2015-03-02
Q3 2013 $14M -$5.73M -29% Sep 30, 2013 10-Q 2013-10-28
Q2 2013 $14.9M -$5.18M -25.8% Jun 30, 2013 10-Q 2013-07-29
Q1 2013 $15.2M -$4.69M -23.6% Mar 31, 2013 10-Q 2013-04-29
Q4 2012 $19.5M +$4.05M +26.1% Dec 31, 2012 10-K 2014-02-26
Q3 2012 $19.7M +$6.18M +45.6% Sep 30, 2012 10-Q 2012-10-29
Q2 2012 $20.1M +$7.79M +63.5% Jun 30, 2012 10-Q 2012-08-02
Q1 2012 $19.8M +$7.62M +62.3% Mar 31, 2012 10-Q 2012-04-30
Q4 2011 $15.5M +$1.28M +9.01% Dec 31, 2011 10-K 2013-02-26
Q3 2011 $13.6M -$215M -94.1% Sep 30, 2011 10-Q 2011-10-31
Q2 2011 $12.3M -$2.29M -15.7% Jun 30, 2011 10-Q 2011-08-01
Q1 2011 $12.2M Mar 31, 2011 10-Q 2011-04-29
Q4 2010 $14.2M Dec 31, 2010 10-K 2012-02-22
Q3 2010 $229M Sep 30, 2010 10-Q 2010-10-29
Q2 2010 $14.6M Jun 30, 2010 10-Q 2010-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.